1 / 5

Gene Editing Market Size, Share, Growth And Trends 2021

A recent report published by Precision Business Insights on Gene Editing Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/3r8Tklo

vamshi_Pbi
Download Presentation

Gene Editing Market Size, Share, Growth And Trends 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gene Editing Market, 2021 - 2027 Copyright ©Precision Business Insights ©2021 Precision Business Insights 1

  2. Market Overview: The worldwide gene editing market is expected to rise due to improved application of genetic engineering and additional funding in the domain of gene editing. The safety and effectiveness of these medicines are important concerns when it comes to bringing gene editing technology to the clinic. The insertion, removal, or replacement of DNA at a specific spot in the genome of a living creature is known as gene editing. Gene editing, also known as genome editing, is a form of genetic engineering technology. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description ©2021 Precision Business Insights 2

  3. Market Segments: The global gene editing market has been fragmented based on: 1. By Technology: Zinc Finger Nuclease (ZFN), Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Others 2. By Product: Consumables, Instruments and Software 3. By End User: Pharmaceutical companies, Biotechnology Companies, Academics, Clinical Research Organizations 4. By Geography: North America, Asia Pacific, Europe, Middle East and Africa, Latin America Request Sample Report ©2021 Precision Business Insights 3

  4. Key Players: Some of the major key players in the gene editing market are: Cellectis S.A. (France), Applied Stemcell, Inc. (U.S.), Genscript (U.S.), Merck KGaA (Germany), Horizon Discovery Group plc,(U.K.), Origene Technologies, Inc. (U.S.), System Biosciences, Inc. (U.S.), Sangamo Therapeutics, Inc.(U.S.), Thermo Fisher Scientific (U.S), and Transposagen Biopharmaceuticals, Inc.(U.S.) Request Sample Report ©2021 Precision Business Insights 4

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, #202, RVS Sree Homes, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad, India – 500084 Email: sales@precisionbusinessinsights.com Toll Free : +1-866-598-1553 ©2021 Precision Business Insights 5 ©2020 Precision Business Insights

More Related